InTandem Capital Partners Completes Strategic Investment in Atlas Health, an Industry-Leading Patient Affordability Platform

InTandem Capital Partners, LP ("InTandem"), a New York-based private equity firm focused on healthcare services, announced that it has completed a strategic growth investment in Atlas Health ("Atlas"), according to a Business Wire release dated October 29, 2026. The announcement did not disclose the investment size or valuation. Atlas Health's management team will continue to lead the company and retain significant shareholdings alongside InTandem.

Founded in 2017, Atlas partners with hospitals and health systems to match and enroll patients in healthcare affordability programs designed to increase coverage and reimbursement while improving patient access, satisfaction, and clinical outcomes. The company's proprietary agentic AI, Ava, is used to help patients facing costly treatments identify and obtain financial assistance. Per the release, Atlas plans to use the new capital to accelerate key product initiatives and invest further in serving providers and patients.

Ethan Davidoff, Founder and CEO of Atlas Health, described patient affordability as a category that health systems increasingly run on dedicated infrastructure, citing EHR integrations and agentic AI spanning revenue cycle and pharmacy operations, including coverage, enrollment, medication access, and financial assistance. He said the investment would extend that infrastructure to specialty pharmacies that fund and deliver patient access.

Brad Coppens, President and Managing Partner at InTandem, said regulatory reform and rising employer healthcare costs are affecting coverage for millions, while specialty drug costs continue to climb. He characterized patient financial navigation as shifting from a back-office function to a front-line revenue recovery tool. Aaron Newman, Principal at InTandem, said the firm had followed the patient affordability space for several years and that Atlas has set the standard for the category.

J.P. Morgan served as exclusive financial advisor to Atlas Health, Cooley LLP as the company's legal counsel, and Greenberg Traurig, LLP as legal counsel to InTandem. InTandem describes itself as focused on healthcare services businesses aligned with the Healthcare Quintuple Aim.", "categories": ["private-equity"], "content_type": "press-release", "keywords": ["patient affordability", "growth investment", "healthcare private equity", "agentic AI", "revenue cycle", "InTandem Capital Partners", "Atlas Health"], "mentioned_companies": ["InTandem Capital Partners", "Atlas Health", "J.P. Morgan", "Cooley LLP", "Greenberg Traurig, LLP"], "mentioned_people": ["Ethan Davidoff", "Brad Coppens", "Aaron Newman"], "has_cta": false, "translated_title": "", "audience_score": 85, "is_stock_tip": false, "audience_reason": "A private equity growth investment in a healthcare services company is institutional deal news that allocators and managers track."}